+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Consumer Health in Finland

  • PDF Icon

    Report

  • 103 Pages
  • September 2024
  • Region: Finland
  • Euromonitor International
  • ID: 2544925
In 2024, consumer health overall in Finland is seeing moderate value growth, primarily influenced by the ongoing economic challenges affecting specific segments such as basic OTC products. As a result, consumers are increasingly opting for generics and basic offerings. At the same time other categories, including vitamins and dietary supplements, digestive remedies, and sports nutrition, are performing more robustly.

The Consumer Health in Finland report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.

Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management and Wellbeing.

Data coverage: Market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

  • Get a detailed picture of the Consumer Health market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.

Table of Contents

EXECUTIVE SUMMARY
  • Consumer health in 2024: The big picture
  • 2024 key trends
  • Competitive landscape
  • Retailing developments
  • What next for consumer health?
MARKET INDICATORS
  • Table 1 Consumer Expenditure on Health Goods and Medical Services: Value 2019-2024
  • Table 2 Life Expectancy at Birth 2019-2024
MARKET DATA
  • Table 3 Sales of Consumer Health by Category: Value 2019-2024
  • Table 4 Sales of Consumer Health by Category: % Value Growth 2019-2024
  • Table 5 NBO Company Shares of Consumer Health: % Value 2020-2024
  • Table 6 LBN Brand Shares of Consumer Health: % Value 2021-2024
  • Table 7 Penetration of Private Label in Consumer Health by Category: % Value 2019-2024
  • Table 8 Distribution of Consumer Health by Format: % Value 2019-2024
  • Table 9 Distribution of Consumer Health by Format and Category: % Value 2024
  • Table 10 Forecast Sales of Consumer Health by Category: Value 2024-2029
  • Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2024-2029
APPENDIX
  • OTC registration and classification
  • Vitamins and dietary supplements registration and classification
  • Self-medication/self-care and preventive medicine
  • Switches
DISCLAIMERDEFINITIONS
SOURCES
  • Summary 1 Research Sources
ANALGESICS IN FINLANDKEY DATA FINDINGS
2024 DEVELOPMENTS
  • Value sales decline for analgesics
  • Topical analgesics sees growth rise, while Orion Oyi maintains overall leadership
  • Paediatric analgesics continues to expand from a small base
PROSPECTS AND OPPORTUNITIES
  • Analgesics faces disappointing forecast period
  • Innovation to drive unit price growth
  • Smaller segments set to perform well
CATEGORY DATA
  • Table 12 Sales of Analgesics by Category: Value 2019-2024
  • Table 13 Sales of Analgesics by Category: % Value Growth 2019-2024
  • Table 14 NBO Company Shares of Analgesics: % Value 2020-2024
  • Table 15 LBN Brand Shares of Analgesics: % Value 2021-2024
  • Table 16 Forecast Sales of Analgesics by Category: Value 2024-2029
  • Table 17 Forecast Sales of Analgesics by Category: % Value Growth 2024-2029
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN FINLANDKEY DATA FINDINGS
2024 DEVELOPMENTS
  • Current value drops in 2024
  • Allergy care records positive growth, and Cloetta Suomi maintains leadership
  • Nasal sprays benefits from increased innovation
PROSPECTS AND OPPORTUNITIES
  • Moderate growth predicted for overall category
  • Combination products set to rise fastest
  • Rapid rises for nasal sprays and pharyngeal preparations
CATEGORY DATA
  • Table 18 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2019-2024
  • Table 19 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2019-2024
  • Table 20 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2020-2024
  • Table 21 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2021-2024
  • Table 22 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2024-2029
  • Table 23 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2024-2029
DIGESTIVE REMEDIES IN FINLANDKEY DATA FINDINGS
2024 DEVELOPMENTS
  • Digestive remedies posts solid growth in 2024
  • Orion maintains overall category leadership
  • Digestive enzymes among strongest segments
PROSPECTS AND OPPORTUNITIES
  • Digestive remedies set to remain on positive growth trajectory
  • IBS treatments to rise rapidly as convenience trend accelerates
  • Solid growth predicted for digestive enzymes and H2 blockers
CATEGORY DATA
  • Table 24 Sales of Digestive Remedies by Category: Value 2019-2024
  • Table 25 Sales of Digestive Remedies by Category: % Value Growth 2019-2024
  • Table 26 NBO Company Shares of Digestive Remedies: % Value 2020-2024
  • Table 27 LBN Brand Shares of Digestive Remedies: % Value 2021-2024
  • Table 28 Forecast Sales of Digestive Remedies by Category: Value 2024-2029
  • Table 29 Forecast Sales of Digestive Remedies by Category: % Value Growth 2024-2029
DERMATOLOGICALS IN FINLANDKEY DATA FINDINGS
2024 DEVELOPMENTS
  • Scabies and new launches support growth in 2024
  • Bayer and Orion maintain leadership
  • Hair loss treatments sees improvement while nappy/rash treatments falls
PROSPECTS AND OPPORTUNITIES
  • Overall category set to expand slightly in terms of value sales
  • Antiparasitics and medicated shampoos anticipated to do well
  • Nappy(diaper) rash treatments will remain in decline
CATEGORY DATA
  • Table 30 Sales of Dermatologicals by Category: Value 2019-2024
  • Table 31 Sales of Dermatologicals by Category: % Value Growth 2019-2024
  • Table 32 NBO Company Shares of Dermatologicals: % Value 2020-2024
  • Table 33 LBN Brand Shares of Dermatologicals: % Value 2021-2024
  • Table 34 LBN Brand Shares of Hair Loss Treatments: % Value 2021-2024
  • Table 35 Forecast Sales of Dermatologicals by Category: Value 2024-2029
  • Table 36 Forecast Sales of Dermatologicals by Category: % Value Growth 2024-2029
NRT SMOKING CESSATION AIDS IN FINLANDKEY DATA FINDINGS
2024 DEVELOPMENTS
  • Sales slump as new regulations take effect
  • Highly consolidated competitive landscape
  • NRT sprays continues to rise in 2024, while Zonnic loses ground
PROSPECTS AND OPPORTUNITIES
  • Sales set to fall further during forecast period
  • Stricter regulations anticipated
  • Little room for value growth
CATEGORY INDICATORS
  • Table 37 Number of Smokers by Gender 2019-2024
CATEGORY DATA
  • Table 38 Sales of NRT Smoking Cessation Aids by Category: Value 2019-2024
  • Table 39 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2019-2024
  • Table 40 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2020-2024
  • Table 41 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2021-2024
  • Table 42 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2024-2029
  • Table 43 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2024-2029
SLEEP AIDS IN FINLANDKEY DATA FINDINGS
2024 DEVELOPMENTS
  • Sleep aids see continued growth in 2024
  • Competition remains intense
  • Melatonin-based products become more prevalent
PROSPECTS AND OPPORTUNITIES
  • Sales set to slow down as competition intensifies
  • Melatonin and combination products will gather ground
  • Herbal variants likely to outpace standard alternatives
CATEGORY DATA
  • Table 44 Sales of Sleep Aids: Value 2019-2024
  • Table 45 Sales of Sleep Aids: % Value Growth 2019-2024
  • Table 46 NBO Company Shares of Sleep Aids: % Value 2020-2024
  • Table 47 LBN Brand Shares of Sleep Aids: % Value 2021-2024
  • Table 48 Forecast Sales of Sleep Aids: Value 2024-2029
  • Table 49 Forecast Sales of Sleep Aids: % Value Growth 2024-2029
EYE CARE IN FINLANDKEY DATA FINDINGS
2024 DEVELOPMENTS
  • Eye care sees positive growth in 2024
  • Bayer remains overall category leader
  • Allergy eye care goes from strength to strength
PROSPECTS AND OPPORTUNITIES
  • Continued though slowing growth forecast for eye care
  • Greater investment in innovation expected to cater to evolving demand
  • Allergy eye care still holds potential for substantial expansion, while ageing population supports sales in standard eye care
CATEGORY DATA
  • Table 50 Sales of Eye Care by Category: Value 2019-2024
  • Table 51 Sales of Eye Care by Category: % Value Growth 2019-2024
  • Table 52 NBO Company Shares of Eye Care: % Value 2020-2024
  • Table 53 LBN Brand Shares of Eye Care: % Value 2021-2024
  • Table 54 Forecast Sales of Eye Care by Category: Value 2024-2029
  • Table 55 Forecast Sales of Eye Care by Category: % Value Growth 2024-2029
WOUND CARE IN FINLANDKEY DATA FINDINGS
2024 DEVELOPMENTS
  • Value sales rise but growth is dampened by cost-consciousness
  • Orkla stays ahead, with players staying focused on innovation
  • Private label expands as consumers seek out value
PROSPECTS AND OPPORTUNITIES
  • Wound care to see strong growth
  • Private label sales will remain supported by consumers’ economic caution and rising trust
  • Value-added offerings set to become more prevalent
CATEGORY DATA
  • Table 56 Sales of Wound Care by Category: Value 2019-2024
  • Table 57 Sales of Wound Care by Category: % Value Growth 2019-2024
  • Table 58 NBO Company Shares of Wound Care: % Value 2020-2024
  • Table 59 LBN Brand Shares of Wound Care: % Value 2021-2024
  • Table 60 Forecast Sales of Wound Care by Category: Value 2024-2029
  • Table 61 Forecast Sales of Wound Care by Category: % Value Growth 2024-2029
VITAMINS IN FINLANDKEY DATA FINDINGS
2024 DEVELOPMENTS
  • Stagnant stales for vitamins in 2024
  • Orkla remains in the lead, followed by Orion, while multivitamins remains diverse
  • Innovation in terms of combination products and updated formats
PROSPECTS AND OPPORTUNITIES
  • Growth hampered by maturity
  • New recommendations may impact development, as other single vitamins strengthens
  • Fragmentation will increase and demand or value-added options will rise
CATEGORY DATA
  • Table 62 Sales of Vitamins by Category: Value 2019-2024
  • Table 63 Sales of Vitamins by Category: % Value Growth 2019-2024
  • Table 64 Sales of Multivitamins by Positioning: % Value 2019-2024
  • Table 65 NBO Company Shares of Vitamins: % Value 2020-2024
  • Table 66 LBN Brand Shares of Vitamins: % Value 2021-2024
  • Table 67 Forecast Sales of Vitamins by Category: Value 2024-2029
  • Table 68 Forecast Sales of Vitamins by Category: % Value Growth 2024-2029
DIETARY SUPPLEMENTS IN FINLANDKEY DATA FINDINGS
2024 DEVELOPMENTS
  • Current value sales rise in 2024
  • Fragmentation persists, while consumers seek out solutions to tackle high stress and low energy
  • Probiotics on the rise, while brain- and memory-targeted offerings see increased innovation
PROSPECTS AND OPPORTUNITIES
  • Value sales set to rise for dietary supplements
  • Probiotics will continue to expand
  • Mineral supplements to benefit from iron’s popularity as convenience trend impacts format development
CATEGORY DATA
  • Table 69 Sales of Dietary Supplements by Category: Value 2019-2024
  • Table 70 Sales of Dietary Supplements by Category: % Value Growth 2019-2024
  • Table 71 Sales of Dietary Supplements by Positioning: % Value 2019-2024
  • Table 72 NBO Company Shares of Dietary Supplements: % Value 2020-2024
  • Table 73 LBN Brand Shares of Dietary Supplements: % Value 2021-2024
  • Table 74 Forecast Sales of Dietary Supplements by Category: Value 2024-2029
  • Table 75 Forecast Sales of Dietary Supplements by Category: % Value Growth 2024-2029
WEIGHT MANAGEMENT AND WELLBEING IN FINLANDKEY DATA FINDINGS
2024 DEVELOPMENTS
  • Category decline persists in 2024
  • Nutricia and Nutrilett head up brands
  • Decline driven by waning consumer interest
PROSPECTS AND OPPORTUNITIES
  • Category faces continued struggle ahead
  • Competition from other categories will have further hamper growth
  • Stagnation for small segments suffering lack of development
CATEGORY DATA
  • Table 76 Sales of Weight Management and Wellbeing by Category: Value 2019-2024
  • Table 77 Sales of Weight Management and Wellbeing by Category: % Value Growth 2019-2024
  • Table 78 NBO Company Shares of Weight Management and Wellbeing: % Value 2020-2024
  • Table 79 LBN Brand Shares of Weight Management and Wellbeing: % Value 2021-2024
  • Table 80 Forecast Sales of Weight Management and Wellbeing by Category: Value 2024-2029
  • Table 81 Forecast Sales of Weight Management and Wellbeing by Category: % Value Growth 2024-2029
SPORTS NUTRITION IN FINLANDKEY DATA FINDINGS
2024 DEVELOPMENTS
  • Sports nutrition forges ahead in 2024
  • Leader foods leads sports nutrition, followed by Celsius Finland
  • Sports non-protein products leads category growth, with candy format attracting attention
PROSPECTS AND OPPORTUNITIES
  • Sports nutrition faces bright future
  • Non-protein variants to see fastest growth
  • Sports RTD will rise strongly, while more products for those on the go will enter the overall category
CATEGORY DATA
  • Table 82 Sales of Sports Nutrition by Category: Value 2019-2024
  • Table 83 Sales of Sports Nutrition by Category: % Value Growth 2019-2024
  • Table 84 NBO Company Shares of Sports Nutrition: % Value 2020-2024
  • Table 85 LBN Brand Shares of Sports Nutrition: % Value 2021-2024
  • Table 86 Forecast Sales of Sports Nutrition by Category: Value 2024-2029
  • Table 87 Forecast Sales of Sports Nutrition by Category: % Value Growth 2024-2029
HERBAL/TRADITIONAL PRODUCTS IN FINLANDKEY DATA FINDINGS
2024 DEVELOPMENTS
  • Natural trend supports category growth in 2024
  • Cloetta Suomi leads highly fragmented competitive landscape
  • Topical analgesics and sleep aids benefit from rising consumer interest
PROSPECTS AND OPPORTUNITIES
  • Herbal/traditional products to maintain positive growth
  • Rising sales for topical analgesics and stress relievers
  • Sleep aids holds potential for further expansion
CATEGORY DATA
  • Table 88 Sales of Herbal/Traditional Products by Category: Value 2019-2024
  • Table 89 Sales of Herbal/Traditional Products by Category: % Value Growth 2019-2024
  • Table 90 NBO Company Shares of Herbal/Traditional Products: % Value 2020-2024
  • Table 91 LBN Brand Shares of Herbal/Traditional Products: % Value 2021-2024
  • Table 92 Forecast Sales of Herbal/Traditional Products by Category: Value 2024-2029
  • Table 93 Forecast Sales of Herbal/Traditional Products by Category: % Value Growth 2024-2029
PAEDIATRIC CONSUMER HEALTH IN FINLANDKEY DATA FINDINGS
2024 DEVELOPMENTS
  • Robust growth driven by immature subcategories
  • GSK Consumer Healthcare maintains overall leadership in 2024
  • Solid growth seen in several segments
PROSPECTS AND OPPORTUNITIES
  • Growth will remain positive but hampered by negative birth rates
  • Vitamins and dietary supplements among fastest risers
  • While nappy (diaper) rash treatments will fall, overall category holds potential for expansion
CATEGORY DATA
  • Table 94 Sales of Paediatric Consumer Health by Category: Value 2019-2024
  • Table 95 Sales of Paediatric Consumer Health by Category: % Value Growth 2019-2024
  • Table 96 NBO Company Shares of Paediatric Consumer Health: % Value 2020-2024
  • Table 97 LBN Brand Shares of Paediatric Consumer Health: % Value 2021-2024
  • Table 98 Forecast Sales of Paediatric Consumer Health by Category: Value 2024-2029
  • Table 99 Forecast Sales of Paediatric Consumer Health by Category: % Value Growth 2024-2029